These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21029260)

  • 21. Microbiological study of the subgingival biofilm in HIV+/HAART patients at a specialized dental service.
    Gliosca LA; D Eramo LR; Bozza FL; Soken L; Abusamra L; Salgado PA; Squassi AF; Molgatini SL
    Acta Odontol Latinoam; 2019 Dec; 32(3):147-155. PubMed ID: 32176238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current classifications of HIV-associated periodontal diseases.
    Smith GL; Felix DH; Wray D
    Br Dent J; 1993 Feb; 174(3):102-5. PubMed ID: 8427729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of HIV associated oral lesions among adults in the era of HAART.
    Mthethwa SR; Wanjau J; Chabikuli N
    SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects and microbiology of HIV-associated periodontal lesions.
    Piluso S; Ficarra G; Orsi A; Gaglioti D; Pierotti P; Orlando S
    Minerva Stomatol; 1993 Jun; 42(6):301-9. PubMed ID: 8232138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV disease as a risk factor for periodontal disease.
    Murray PA
    Compendium; 1994 Aug; 15(8):1052, 1054-63; quiz 1064. PubMed ID: 7987897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cases of HIV-associated characteristic periodontal diseases.
    Pistorius A; Willershausen B
    Eur J Med Res; 1999 Mar; 4(3):121-5. PubMed ID: 10085280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Most common oral manifestations in pediatric patients HIV positive and the effect of highly active antiretroviral therapy.
    Araújo JF; Oliveira AEF; Carvalho HLCC; Roma FRVO; Lopes FF
    Cien Saude Colet; 2018 Jan; 23(1):115-122. PubMed ID: 29267817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Necrotizing periodontal diseases in HIV-infected Brazilian patients: a clinical and microbiologic descriptive study.
    Ramos MP; Ferreira SM; Silva-Boghossian CM; Souto R; Colombo AP; Noce CW; Gonçalves LS
    Quintessence Int; 2012 Jan; 43(1):71-82. PubMed ID: 22259811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral lesions in infection with human immunodeficiency virus.
    Coogan MM; Greenspan J; Challacombe SJ
    Bull World Health Organ; 2005 Sep; 83(9):700-6. PubMed ID: 16211162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of highly-active antiretroviral therapy on the subgingival biofilm in HIV-infected patients.
    Jordan RA; Lucaciu A; Zimmer S
    J Investig Clin Dent; 2016 Feb; 7(1):65-71. PubMed ID: 25283543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
    Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
    AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral infectious diseases: a potential risk factor for HIV virus recrudescence?
    González OA; Ebersole JL; Huang CB
    Oral Dis; 2009 Jul; 15(5):313-27. PubMed ID: 19364391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly-active antiretroviral therapy and oral opportunistic microorganisms in HIV-positive individuals of Thailand.
    Arirachakaran P; Poovorawan Y; Dahlén G
    J Investig Clin Dent; 2016 May; 7(2):158-67. PubMed ID: 25537925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA probe detection of periodontal pathogens in HIV-associated periodontal lesions.
    Murray PA; Winkler JR; Peros WJ; French CK; Lippke JA
    Oral Microbiol Immunol; 1991 Feb; 6(1):34-40. PubMed ID: 1945481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dental lesions: diagnosis and treatment.
    Phelan JA
    Oral Dis; 1997 May; 3 Suppl 1():S235-7. PubMed ID: 9456696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term use of HAART on oral health status of HIV-infected subjects.
    Nittayananta W; Talungchit S; Jaruratanasirikul S; Silpapojakul K; Chayakul P; Nilmanat A; Pruphetkaew N
    J Oral Pathol Med; 2010 May; 39(5):397-406. PubMed ID: 20202089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral manifestations of HIV disease.
    Reznik DA
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):143-8. PubMed ID: 16377852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of candida and periodontal disease in immunocompetent and HIV-infected subjects.
    Feller L; Buskin A; Blignaut E
    SADJ; 2005 May; 60(4):152-4. PubMed ID: 15974431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus.
    J Oral Pathol Med; 1993 Aug; 22(7):289-91. PubMed ID: 8229864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.